BCL2 and cancer: HMGB1 KD was reported to increase drug sensitivity in cancer cells, and it was assumed that HMGB1 plays transcription-dependent (such as regulation of Bcl-2 family protein expression) and transcription-independent roles (such as regulation of autophagy and p53 location) in the regulation of apoptosis (reviewed in [42]).